Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01402947 · ClinicalTrials.gov registry record · Phase 1
Ciprofloxacin XR Drug Interaction Study With MMX® Mesalazine/Mesalamine
A Phase 1 study, sponsored by Shire.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT01402947 is a Phase 1 study that has completed, run by Shire. The registered enrollment target is 30 participants.
The verdict
NCT01402947, a Phase 1 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a drug interaction study evaluating the pharmacokinetic profiles of Ciprofloxacin XR administered alone \& in combination with MMX Mesalazine/mesalamine.
Interventions
- DRUG Ciprofloxacin XR + MMX Placebo
- DRUG MMX Mesalazine/mesalamine + Ciprofloxacin XR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-07-25 |
| Est. Completion | 2011-08-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01402947
The ClinicalTrials.gov registry entry for NCT01402947 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ciprofloxacin XR + MMX Placebo is the first listed.
NCT01402947 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01402947 about?
NCT01402947 is a clinical study titled "Ciprofloxacin XR Drug Interaction Study With MMX® Mesalazine/Mesalamine". This is a drug interaction study evaluating the pharmacokinetic profiles of Ciprofloxacin XR administered alone \& in combination with MMX Mesalazine/mesalamine.
What is the current status of trial NCT01402947?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2011-07-25. Estimated completion is 2011-08-30.
What interventions are being tested in trial NCT01402947?
The interventions under investigation include: Ciprofloxacin XR + MMX Placebo (DRUG), MMX Mesalazine/mesalamine + Ciprofloxacin XR (DRUG).
Who is sponsoring clinical trial NCT01402947?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.